Ajay Soodan, MD
Clinical Cardiac Electrophysiology · Pikesville, MDNPI 1336175884
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $4,629 and has fallen 75.6% since, to $1,131 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MD, where the typical reported total is $15,262.
Across 140 payments — averaging $84.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Abbott$533
- Boston Scientific$387
- Biosense Webster, Inc.$352
- Kestra Medical Technology Services, Inc.$328
- Edwards Lifesciences$193
- plus $1K from 20 others
What the payments were for
- Travel & lodging$5,48346%
- Food & beverage$6,37654%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 74 | $8,659 |
| Abbott | 6 | $533 |
| Boston Scientific | 6 | $387 |
| Biosense Webster, Inc. | 3 | $352 |
| Kestra Medical Technology Services, Inc. | 4 | $328 |
| Edwards Lifesciences | 1 | $193 |
| Atricure, Inc. | 2 | $189 |
| Johnson & Johnson | 6 | $169 |
| E.r. Squibb & Sons, L.L.C. | 9 | $165 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $145 |
| Inari Medical, Inc. | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $116 |
| Sanofi-aventis U.S. LLC | 2 | $100 |
| Preventice Services, LLC | 1 | $76 |
| Pfizer | 3 | $71 |
| Novartis | 3 | $71 |
| Boehringer Ingelheim | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Philips North America LLC | 1 | $22 |
| Akcea Therapeutics, Inc. | 1 | $20 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Biotronik Inc. | 1 | $18 |
| GE HealthCare | 1 | $16 |
| Amgen | 1 | $15 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arctic Front$1,199
- Micra$363
- Visia AF$288
- Carto 3$256
- AZURE XT DR MRI SURESCAN$252
- Azure$217
- Edwards SAPIEN 3 Transcatheter Heart Valve$193
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$165
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$146
- Assure WCD$145
- AFFERA MAPPING SYSTEM$132
- FLOWTRIEVER CATHETER, S$125
- CT THROMBECTOMY SYSTEM KIT$125
- ENSITE PRECISION$121
- Vascepa$116
- Watchman$113
- Farapulse$109
How this compares
$11,877 in reported general payments places this provider in the 45th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
See all clinical cardiac electrophysiology providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 231 | $304,168 |
| EntrestoSacubitril/Valsartan | 144 | $206,898 |
| XareltoRivaroxaban | 43 | $66,509 |
| JardianceEmpagliflozin | 15 | $22,371 |
| Metoprolol Succinate | 220 | $5,289 |
| Carvedilol | 186 | $2,803 |
| Atorvastatin Calcium | 142 | $2,306 |
| Rosuvastatin Calcium | 56 | $1,712 |
| Amiodarone Hcl | 72 | $1,476 |
| Pravastatin Sodium | 61 | $1,359 |
| Losartan Potassium | 110 | $1,349 |
| Spironolactone | 128 | $1,335 |
| Lisinopril | 103 | $1,044 |
| Amlodipine Besylate | 119 | $972 |
| Hydralazine Hcl | 43 | $940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $71 | $304,168231 claims |
| NovartisEntresto | $71 | $206,898144 claims |
| Johnson & JohnsonXarelto | $169 | $66,50943 claims |
| Boehringer IngelheimJardiance | $28 | $22,37115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
Other clinical cardiac electrophysiology in Pikesville
- Sean BeinartRockville$315K
- Charles LoveBaltimore$238K
- Hugh CalkinsBaltimore$202K
- Paresh ShahBaltimore$97K
- Helen BaroldRockville$83K
- Jonathan ChrispinBaltimore$77K
- Sung LeeTakoma Park$68K
- Stephen ShorofskyBaltimore$63K
- Nilofar IslamTowson$61K
- Arooge TowheedLargo$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.